IBDEI0N9 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,10351,1,3,0)
 ;;=3^Dermatochalasis,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10351,1,4,0)
 ;;=4^H02.834
 ;;^UTILITY(U,$J,358.3,10351,2)
 ;;=^5004421
 ;;^UTILITY(U,$J,358.3,10352,0)
 ;;=H10.31^^74^677^14
 ;;^UTILITY(U,$J,358.3,10352,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10352,1,3,0)
 ;;=3^Conjunctivitis,Acute,Right Eye
 ;;^UTILITY(U,$J,358.3,10352,1,4,0)
 ;;=4^H10.31
 ;;^UTILITY(U,$J,358.3,10352,2)
 ;;=^5133458
 ;;^UTILITY(U,$J,358.3,10353,0)
 ;;=H10.32^^74^677^13
 ;;^UTILITY(U,$J,358.3,10353,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10353,1,3,0)
 ;;=3^Conjunctivitis,Acute,Left Eye
 ;;^UTILITY(U,$J,358.3,10353,1,4,0)
 ;;=4^H10.32
 ;;^UTILITY(U,$J,358.3,10353,2)
 ;;=^5133459
 ;;^UTILITY(U,$J,358.3,10354,0)
 ;;=H00.11^^74^677^12
 ;;^UTILITY(U,$J,358.3,10354,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10354,1,3,0)
 ;;=3^Chalazion,Right Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10354,1,4,0)
 ;;=4^H00.11
 ;;^UTILITY(U,$J,358.3,10354,2)
 ;;=^5004233
 ;;^UTILITY(U,$J,358.3,10355,0)
 ;;=H00.14^^74^677^11
 ;;^UTILITY(U,$J,358.3,10355,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10355,1,3,0)
 ;;=3^Chalazion,Left Upper Eyelid
 ;;^UTILITY(U,$J,358.3,10355,1,4,0)
 ;;=4^H00.14
 ;;^UTILITY(U,$J,358.3,10355,2)
 ;;=^5004236
 ;;^UTILITY(U,$J,358.3,10356,0)
 ;;=H20.00^^74^677^34
 ;;^UTILITY(U,$J,358.3,10356,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10356,1,3,0)
 ;;=3^Iridocyclitis,Acute/Subacute,Unspec
 ;;^UTILITY(U,$J,358.3,10356,1,4,0)
 ;;=4^H20.00
 ;;^UTILITY(U,$J,358.3,10356,2)
 ;;=^5005133
 ;;^UTILITY(U,$J,358.3,10357,0)
 ;;=B00.59^^74^677^32
 ;;^UTILITY(U,$J,358.3,10357,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10357,1,3,0)
 ;;=3^Herpes Viral Eye Disease NEC
 ;;^UTILITY(U,$J,358.3,10357,1,4,0)
 ;;=4^B00.59
 ;;^UTILITY(U,$J,358.3,10357,2)
 ;;=^5000476
 ;;^UTILITY(U,$J,358.3,10358,0)
 ;;=Z01.00^^74^677^30
 ;;^UTILITY(U,$J,358.3,10358,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10358,1,3,0)
 ;;=3^Eye/Vision Exam w/o Abnormal Findings
 ;;^UTILITY(U,$J,358.3,10358,1,4,0)
 ;;=4^Z01.00
 ;;^UTILITY(U,$J,358.3,10358,2)
 ;;=^5062612
 ;;^UTILITY(U,$J,358.3,10359,0)
 ;;=Z01.01^^74^677^29
 ;;^UTILITY(U,$J,358.3,10359,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10359,1,3,0)
 ;;=3^Eye/Vision Exam w/ Abnormal Findings
 ;;^UTILITY(U,$J,358.3,10359,1,4,0)
 ;;=4^Z01.01
 ;;^UTILITY(U,$J,358.3,10359,2)
 ;;=^5062613
 ;;^UTILITY(U,$J,358.3,10360,0)
 ;;=H52.213^^74^677^2
 ;;^UTILITY(U,$J,358.3,10360,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10360,1,3,0)
 ;;=3^Astigmatism,Irregular,Bilateral
 ;;^UTILITY(U,$J,358.3,10360,1,4,0)
 ;;=4^H52.213
 ;;^UTILITY(U,$J,358.3,10360,2)
 ;;=^5006272
 ;;^UTILITY(U,$J,358.3,10361,0)
 ;;=H52.223^^74^677^3
 ;;^UTILITY(U,$J,358.3,10361,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10361,1,3,0)
 ;;=3^Astigmatism,Regular,Bilateral
 ;;^UTILITY(U,$J,358.3,10361,1,4,0)
 ;;=4^H52.223
 ;;^UTILITY(U,$J,358.3,10361,2)
 ;;=^5006276
 ;;^UTILITY(U,$J,358.3,10362,0)
 ;;=H40.1113^^74^677^49
 ;;^UTILITY(U,$J,358.3,10362,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10362,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage,Right Eye
 ;;^UTILITY(U,$J,358.3,10362,1,4,0)
 ;;=4^H40.1113
 ;;^UTILITY(U,$J,358.3,10362,2)
 ;;=^5138539
 ;;^UTILITY(U,$J,358.3,10363,0)
 ;;=H40.1123^^74^677^50
 ;;^UTILITY(U,$J,358.3,10363,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,10363,1,3,0)
 ;;=3^Primary Open-Angle Glaucoma,Severe Stage,Left Eye
